Analytical Data
-
基因名
CPA5
- Application
-
别名
CPA5；Carboxypeptidase A5
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WXQ8
-
表达区间
127-436aa
-
氨基酸序列
LERS TNSFSYSSYH TLEEIYSWID NFVMEHSDIV SKIQIGNSFE NQSILVLKFS TGGSRHPAIW IDTGIHSREW ITHATGIWTA NKIVSDYGKD RVLTDILNAM DIFIELVTNP DGFAFTHSMN RLWRKNKSIR PGIFCIGVDL NRNWKSGFGG NGSNSNPCSE TYHGPSPQSE PEVAAIVNFI TAHGNFKALI SIHSYSQMLM YPYGRLLEPV SNQRELYDLA KDAVEALYKV HGIEYIFGSI STTLYVASGI TVDWAYDSGI KYAFSFELRD TGQYGFLLPA TQIIPTAQET WMALRTIMEH TLNHPY
-
分子量
49 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The CPA5 protein, a member of the calcium-dependent phospholipid-binding protein family, has gained attention in recent years due to its potential roles in various biological processes and implications in diseases. Research has shown that CPA5 is involved in cellular signaling pathways, particularly in regulating inflammation and apoptosis, which are critical in immune responses and cancer progression. Its expression levels have been associated with several pathological conditions, including autoimmune diseases and malignancies, making it a candidate for therapeutic targeting and biomarker development. Furthermore, structural studies of CPA5 have revealed insights into its binding mechanisms and interactions with lipid membranes, which are essential for understanding its functional role in health and disease. The ongoing exploration of CPA5's structure, function, and biological significance aims to elucidate its contributions to pathophysiological processes, potentially leading to novel strategies for disease intervention and treatment.
